Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival …

K Swedberg, P Held, J Kjekshus… - … England Journal of …, 1992 - Mass Medical Soc
Background. Long-term administration of angiotensin-converting—enzyme (ACE) inhibitors
has been shown to improve survival in patients with symptomatic left ventricular failure and …

[引用][C] Early and late angiotensin-converting enzyme inhibition after myocardial infarction: an overview of randomized clinical trials

E Ambrosioni, C Borghi - The American journal of medicine, 2003 - amjmed.com
An association between the activation of the renin-angiotensin-aldosterone system and the
development of atherosclerotic disease and its complications has been demonstrated in …

Cardiovascular protection by angiotensin-converting enzyme inhibition

R Ferrari - European Heart Journal Supplements, 2009 - academic.oup.com
One of the most important health achievements during the twentieth century was the
unravelling of the causes of the cardiovascular diseases (CVDs). Since the 1980s, coronary …

Angiotensin receptor blockers reduce cardiovascular events, including the risk of myocardial infarction

FH Messerli, S Bangalore - Circulation, 2017 - Am Heart Assoc
Angiotensin Receptor Blockers Reduce Cardiovascular Events, Including the Risk of
Myocardial Infarction | Circulation Science Volunteer Warning signs SearchSearch …

Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials

S Bangalore, S Kumar, J Wetterslev, FH Messerli - Bmj, 2011 - bmj.com
Objectives To evaluate the cardiovascular outcomes and other outcomes associated with
angiotensin receptor blockers. Design Systematic review of randomised controlled trials with …

Role of valsartan and other angiotensin receptor blocking agents in the management of cardiovascular disease

J Martin, H Krum - Pharmacological research, 2002 - Elsevier
Blockade of the renin–angiotensin system by angiotensin converting enzyme (ACE)
inhibitors reduces mortality and morbidity in patients post-myocardial infarction as well as in …

[引用][C] Angiotensin receptor blockers and ACE inhibitors are similarly effective in chronic heart failure and in high-risk acute myocardial infarction. Commentary.

DS Roffman - Evidence-based Cardiovascular Medicine, 2005 - europepmc.org
Angiotensin receptor blockers and ACE inhibitors are similarly effective in chronic heart failure
and in high-risk acute myocardial infarction. Commentary. - Abstract - Europe PMC Sign in …

An economic evaluation of valsartan for post-MI patients in the UK who are not suitable for treatment with ACE inhibitors

M Taylor, PA Scuffham, S Chaplin, NL Papo - Value in health, 2009 - Elsevier
OBJECTIVES: The overall objective of this study was to estimate the costs and outcomes
associated with treatment with valsartan for post-myocardial infarction (post-MI) patients with …

Angiotensin-converting enzyme inhibitors reduce mortality compared to angiotensin receptor blockers: Systematic review and meta-analysis

GLO Salvador, VM Marmentini… - European Journal of …, 2017 - academic.oup.com
Background There are few reviews comparing the long-term outcomes of the use of
angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in a …

The benefits of sacubitril–valsartan in patients with acute myocardial infarction: a systematic review and meta‐analysis

B Xiong, D Nie, J Qian, Y Yao, G Yang… - ESC heart …, 2021 - Wiley Online Library
Aims We aimed to investigate whether sacubitril–valsartan could further improve the
prognosis, cardiac function, and left ventricular (LV) remodelling in patients following acute …